Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib

PURPOSE: Patients with advanced GIST following standard imatinib and sunitinib often have good performance status and need additional therapy. This study tested nilotinib, a second-generation tyrosine kinase inhibitor, in patients with advanced GIST refractory to standard therapies. METHODS: This si...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cauchi, C., Somaiah, N., Engstrom, P. F., Litwin, S., Lopez, M., Lee, J., Davey, M., Bove, B., von Mehren, M.
Format: Artigo
Idioma:Inglês
Publicat: Springer-Verlag 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3313017/
https://ncbi.nlm.nih.gov/pubmed/22119758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1785-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars